Evidence map›Paper›PMID 29425496›Full record

ArticleCell reports2018

The Role of Ceramide Synthases in the Pathogenicity of Cryptococcus neoformans.

Mansa A Munshi, Justin M Gardin, Ashutosh Singh, Chiara Luberto, Robert Rieger, Tejas Bouklas, Bettina C Fries, Maurizio Del Poeta

Abstract read
In one paragraph

Article in Cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Toxoplasma ceramide synthases: Gene duplication, functional divergence, and roles in parasite fitness.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  11. Role of sphingolipids in the host-pathogen interaction.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2023
    Article
  12. Article
  13. Identification ofFrontiers in cellular and infection microbiology · 2022
    Article
  14. Article
  15. Low Glucose Mediated Fluconazole Tolerance inJournal of fungi (Basel, Switzerland) · 2021
    Article
  16. Article
  17. The Future of Antifungal Drug Therapy: Novel Compounds and Targets.Antimicrobial agents and chemotherapy · 2021
    Review
  18. Review
  19. Mass Spectrometric Analysis of Bioactive Sphingolipids in Fungi.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mansa A MunshiDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794, USA.
Justin M GardinThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Ashutosh SinghDepartment of Biochemistry, University of Lucknow, Lucknow, Uttar Pradesh 226007, India.
Chiara LubertoDepartment of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11794, USA.
Robert RiegerProteomics Center, Stony Brook University, Stony Brook, NY 11794, USA.
Tejas BouklasDepartment of Biomedical Sciences, School of Health Professions and Nursing, Long Island University, Brookville, NY 11548, USA.
Bettina C FriesDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794, USA; Division of Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
Maurizio Del PoetaDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794, USA; Division of Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; Veterans Administration Medical Center, Northport, NY 11768, USA. Electronic address: maurizio.delpoeta@stonybrook.edu.

Funding

Sphingolipids in Cancer Therapy and AngiogenesisP01CA097132 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI Daniel Canals · 2003 to 2026
$30.8M
New antifungals targeting the synthesis of fungal sphingolipidsR01AI116420 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI Maurizio Del Poeta · 2016 to 2026
$7.6M
Lipid-mediated fungal pathogenesisR01AI125770 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI DEL POETA, MAURIZIO · 2016 to 2025
$6.2M
Investigation on Replicative aging in Cryptococcus neoformans populationsR01AI127704 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI FRIES, BETTINA · 2017 to 2021
$3.2M
Investigation on Replicative aging in Cryptococcus neoformans populationsR56AI127704 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI FRIES, BETTINA · 2023 to 2023
$555k
BLRD VA I01 BX003741NCI NIH HHS P01 CA097132NIAID NIH HHS R01 AI116420NIAID NIH HHS R01 AI125770NIAID NIH HHS R01 AI127704NIAID NIH HHS R56 AI127704
6 · The paper itself

Abstract

Cryptococcus neoformans (C. neoformans) is estimated to cause about 220,000 new cases every year in patients with AIDS, despite advances in antifungal treatments. C. neoformans possesses a remarkable ability to disseminate through an immunocompromised host, making treatment difficult. Here, we examine the mechanism of survival of C. neoformans under varying host conditions and find a role for ceramide synthase in C. neoformans virulence. This study also provides a detailed lipidomics resource for the fungal lipid research community in addition to discovering a potential target for antifungal therapy.

Indexed as

AnimalsCryptococcosisCryptococcus neoformansFemaleFungal ProteinsMiceOxidoreductasesVirulenceVirulence Factorsdihydroceramide desaturaseFungal ProteinsOxidoreductasesVirulence Factorsceramideceramide synthaseCryptococcus neoformansfungiinfectious diseasespathogenicitysphingolipidsvirulenceyeasts

Identifiers

PMID29425496
PMCPMC5839121

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.